HK1206725A1 - 炔雜芳環化合物及其應用 - Google Patents
炔雜芳環化合物及其應用Info
- Publication number
- HK1206725A1 HK1206725A1 HK15107197.9A HK15107197A HK1206725A1 HK 1206725 A1 HK1206725 A1 HK 1206725A1 HK 15107197 A HK15107197 A HK 15107197A HK 1206725 A1 HK1206725 A1 HK 1206725A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkynyl
- application
- heteroaromatic ring
- ring compound
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210344248 | 2012-09-17 | ||
PCT/CN2013/083402 WO2014040549A1 (zh) | 2012-09-17 | 2013-09-12 | 炔杂芳环化合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206725A1 true HK1206725A1 (zh) | 2016-01-15 |
Family
ID=50277633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107197.9A HK1206725A1 (zh) | 2012-09-17 | 2015-07-28 | 炔雜芳環化合物及其應用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150152088A1 (zh) |
EP (1) | EP2896620A4 (zh) |
JP (1) | JP2015524448A (zh) |
KR (1) | KR20150067140A (zh) |
CN (1) | CN103664787B (zh) |
AU (1) | AU2013314839A1 (zh) |
HK (1) | HK1206725A1 (zh) |
WO (1) | WO2014040549A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2979481B1 (fr) | 2011-08-25 | 2016-07-01 | Commissariat Energie Atomique | Procede de realisation d'un circuit integre tridimensionnel |
US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
WO2015058661A1 (zh) * | 2013-10-23 | 2015-04-30 | 南京圣和药业股份有限公司 | Bcr-abl激酶抑制剂及其应用 |
GB2522226A (en) * | 2014-01-17 | 2015-07-22 | Agency Science Tech & Res | Heteroaryl alkyne derivatives and uses thereof |
US9233968B1 (en) * | 2014-10-27 | 2016-01-12 | Allergan, Inc. | Kinase inhibitors |
US20170252350A1 (en) | 2016-03-03 | 2017-09-07 | Cornell University | Small molecule ire1-alpha inhibitors |
US11117883B2 (en) * | 2016-12-15 | 2021-09-14 | Ariad Pharmaceuticals, Inc. | Benzimidazole compounds as c-Kit inhibitors |
WO2018161033A1 (en) * | 2017-03-02 | 2018-09-07 | Wright, Adrian | Small molecule ire1-alpha inhibitors |
US11273126B2 (en) | 2017-03-15 | 2022-03-15 | Sun Pharma Advanced Research Company Limited | Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide |
WO2019013703A1 (en) * | 2017-07-14 | 2019-01-17 | Agency For Science, Technology And Research (A*Star) | BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF |
BR112020015581A2 (pt) | 2018-01-31 | 2021-02-02 | Deciphera Pharmaceuticals, Llc | terapia de combinação para o tratamento de tumores estromais gastrointestinais |
KR102205619B1 (ko) * | 2019-06-12 | 2021-01-21 | 한국과학기술연구원 | 신규한 인다졸 유도체 화합물 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물 |
JP2022544234A (ja) | 2019-08-12 | 2022-10-17 | デシフェラ・ファーマシューティカルズ,エルエルシー | 胃腸間質腫瘍を治療するためのリプレチニブ |
WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
EP4327827A3 (en) | 2019-12-30 | 2024-05-29 | Deciphera Pharmaceuticals, LLC | Amorphous kinase inhibitor formulations and methods of use thereof |
IL293864A (en) | 2019-12-30 | 2022-08-01 | Deciphera Pharmaceuticals Llc | Preparations of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3- phenylurea |
CN115043832B (zh) * | 2021-03-08 | 2023-08-22 | 药雅科技(上海)有限公司 | 一种fgfr抑制剂炔代杂环类化合物及其制备方法和用途 |
CN114656470B (zh) * | 2022-04-19 | 2023-11-10 | 辽宁大学 | 取代喹唑啉类化合物及其制备方法和应用 |
US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW225528B (zh) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
US20100041657A1 (en) * | 2005-05-11 | 2010-02-18 | Novo Nordick A/S | Haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
CN101389338B (zh) * | 2005-12-23 | 2013-06-26 | 阿里亚德医药股份有限公司 | 双环杂芳基化合物 |
SI2495016T1 (sl) * | 2005-12-23 | 2020-04-30 | Ariad Pharmaceuticals, Inc. | Biciklične heteroarilne spojine |
AU2007249924B2 (en) * | 2006-05-08 | 2013-07-04 | Ariad Pharmaceuticals, Inc. | Acetylenic heteroaryl compounds |
CN101490053B (zh) * | 2006-05-08 | 2013-09-11 | 阿里亚德医药股份有限公司 | 单环杂芳基化合物 |
CN103370324B (zh) * | 2010-12-27 | 2016-05-18 | 孙树萍 | 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途 |
JP5905028B2 (ja) * | 2011-01-21 | 2016-04-20 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | ジアリールアセチレンヒドラジドを含有するチロシンキナーゼ阻害剤 |
AU2012220620A1 (en) * | 2011-02-23 | 2013-10-03 | Icahn School Of Medicine At Mount Sinai | Inhibitors of bromodomains as modulators of gene expression |
RU2477723C2 (ru) * | 2011-06-16 | 2013-03-20 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
-
2013
- 2013-08-29 CN CN201310384570.0A patent/CN103664787B/zh active Active
- 2013-09-12 KR KR1020157006084A patent/KR20150067140A/ko not_active Application Discontinuation
- 2013-09-12 AU AU2013314839A patent/AU2013314839A1/en not_active Abandoned
- 2013-09-12 EP EP13837393.1A patent/EP2896620A4/en not_active Withdrawn
- 2013-09-12 JP JP2015525730A patent/JP2015524448A/ja active Pending
- 2013-09-12 WO PCT/CN2013/083402 patent/WO2014040549A1/zh active Application Filing
- 2013-09-12 US US14/418,105 patent/US20150152088A1/en not_active Abandoned
-
2015
- 2015-07-28 HK HK15107197.9A patent/HK1206725A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2896620A1 (en) | 2015-07-22 |
KR20150067140A (ko) | 2015-06-17 |
EP2896620A4 (en) | 2016-03-02 |
WO2014040549A1 (zh) | 2014-03-20 |
JP2015524448A (ja) | 2015-08-24 |
AU2013314839A1 (en) | 2015-02-05 |
CN103664787B (zh) | 2015-09-09 |
US20150152088A1 (en) | 2015-06-04 |
CN103664787A (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206725A1 (zh) | 炔雜芳環化合物及其應用 | |
IL274355B (en) | Aza-pyridone compounds and their uses | |
HK1207069A1 (zh) | 雜環化合物及其應用 | |
HRP20180635T1 (hr) | Pirazolamidni spoj i njegova upotreba u medicini | |
IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
HK1199023A1 (zh) | 取代的苯並噻吩基-吡咯並三嗪及其用途 | |
EP2907802A4 (en) | CYCLOPROPANAMINE COMPOUND AND USE THEREOF | |
EP2821401A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
IL251974B (en) | Antifibrosis compounds and their uses | |
EP2886546A4 (en) | Heterocyclic compound and use thereof | |
GB201323008D0 (en) | Compounds and uses thereof | |
AP3611A (en) | Heterocyclic compounds and their uses | |
EP2928875A4 (en) | FUNGICIDE COMPOUND AND USES THEREOF | |
ZA201405393B (en) | Aryloxyacetamide compound and pesticide | |
GB201307233D0 (en) | Compounds and uses thereof | |
PL2882708T3 (pl) | Nowe związki i ich zastosowania | |
EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
HK1223307A1 (zh) | 新型化合物和其用途 | |
EP2837632A4 (en) | COMPOUND JK12A AND ITS PREPARATION | |
EP2752413A4 (en) | QUINAZOLINE DERIVATIVE AND ITS APPLICATION | |
GB201206998D0 (en) | New compound and uses | |
GB201222342D0 (en) | Compounds and uses thereof | |
GB201323005D0 (en) | Compounds and uses thereof | |
GB201207075D0 (en) | New compounds and uses | |
GB201206973D0 (en) | New compounds and uses |